ALMOTRIPTAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Almotriptan, and what generic alternatives are available?
Almotriptan is a drug marketed by Ajanta Pharma Ltd, Mylan, and Teva Pharms Usa. and is included in three NDAs.
The generic ingredient in ALMOTRIPTAN is almotriptan malate. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the almotriptan malate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Almotriptan
A generic version of ALMOTRIPTAN was approved as almotriptan malate by TEVA PHARMS USA on July 7th, 2015.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ALMOTRIPTAN?
- What are the global sales for ALMOTRIPTAN?
- What is Average Wholesale Price for ALMOTRIPTAN?
Summary for ALMOTRIPTAN
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Drug Prices: | Drug price information for ALMOTRIPTAN |
| DailyMed Link: | ALMOTRIPTAN at DailyMed |


